Jeff Smith

3.3k total citations · 3 hit papers
52 papers, 2.4k citations indexed

About

Jeff Smith is a scholar working on Psychiatry and Mental health, Surgery and Physiology. According to data from OpenAlex, Jeff Smith has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 12 papers in Surgery and 10 papers in Physiology. Recurrent topics in Jeff Smith's work include Migraine and Headache Studies (17 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (6 papers). Jeff Smith is often cited by papers focused on Migraine and Headache Studies (17 papers), Helicobacter pylori-related gastroenterology studies (8 papers) and Gastroesophageal reflux and treatments (6 papers). Jeff Smith collaborates with scholars based in United States, United Kingdom and Australia. Jeff Smith's co-authors include Joe Hirman, Roger Cady, David M. Biondi, Barbara Schaeffler, Susan Pederson, R E Pounder, Richard B. Lipton, Brent Allan, Peter J. Goadsby and A. M. Sawyerr and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Jeff Smith

50 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

2014 299 citations David W. Dodick, Peter J. Goadsby et al. The Lancet Neurology profile →
Efficacy and safety of eptinezumab in patients with chronic migraine

2020 273 citations Richard B. Lipton, Peter J. Goadsby et al. Neurology profile →
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

2020 264 citations Messoud Ashina, Roger Cady et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Smith United States	25	1.2k	873	758	446	277	52	2.4k
Franck Skobieranda United States	26	695 0.6×	423 0.5×	1.6k 2.0×	885 2.0×	32 0.1×	47	3.3k
Alexander Mauskop United States	27	1.4k 1.2×	800 0.9×	789 1.0×	342 0.8×	12 0.0×	51	2.6k
Søren Schifter Denmark	25	599 0.5×	438 0.5×	542 0.7×	389 0.9×	13 0.0×	71	2.6k
Lars Neeb Germany	26	1.3k 1.1×	667 0.8×	480 0.6×	103 0.2×	19 0.1×	72	1.7k
William Pryse‐Phillips Canada	24	1.1k 0.9×	792 0.9×	424 0.6×	393 0.9×	13 0.0×	60	2.8k
David Bates United Kingdom	20	100 0.1×	547 0.6×	283 0.4×	252 0.6×	53 0.2×	35	3.5k
Shashidhar Kori United States	19	654 0.6×	402 0.5×	316 0.4×	246 0.6×	25 0.1×	46	1.1k
Jan Calissendorff Sweden	27	132 0.1×	432 0.5×	232 0.3×	448 1.0×	30 0.1×	85	2.0k
Friedrich Ebinger Germany	24	505 0.4×	192 0.2×	196 0.3×	256 0.6×	27 0.1×	74	1.9k
Isao Araki Japan	29	104 0.1×	161 0.2×	284 0.4×	244 0.5×	84 0.3×	110	2.3k

Countries citing papers authored by Jeff Smith

Since Specialization

Citations

This map shows the geographic impact of Jeff Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Smith more than expected).

Fields of papers citing papers by Jeff Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Smith. The network helps show where Jeff Smith may publish in the future.

Co-authorship network of co-authors of Jeff Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Smith. A scholar is included among the top collaborators of Jeff Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Smith. Jeff Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Jeff, et al.. (2025). Phylogeny of Core Molecular Components of Metazoan Circadian Clocks. Journal of Biological Rhythms. 41(2). 227–242. 1 indexed citations

Rajan, Shiny Amala Priya, Jason Sherfey, Lauren M. Nichols, et al.. (2023). A Novel Milli-fluidic Liver Tissue Chip with Continuous Recirculation for Predictive Pharmacokinetics Applications. The AAPS Journal. 25(6). 102–102. 17 indexed citations

Bartlett, John M.S., Yutaka Amemiya, Heleen H. Arts, et al.. (2021). Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours. PLoS ONE. 16(10). e0258188–e0258188. 7 indexed citations

Silberstein, Stephen D., Merle L. Diamond, Nada Hindiyeh, et al.. (2020). Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study. The Journal of Headache and Pain. 21(1). 120–120. 72 indexed citations

Lipton, Richard B., Peter J. Goadsby, Jeff Smith, et al.. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine. Neurology. 94(13). e1365–e1377. 273 indexed citations breakdown →

Smith, Timothy R., Marina Janelidze, Roger Cady, et al.. (2020). Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study. Clinical Therapeutics. 42(12). 2254–2265.e3. 41 indexed citations

Dodick, David W., Timothy R. Smith, Roger Cady, et al.. (2019). Eptinezumab Demonstrates Early Relief from Episodic and Chronic Migraine: Consistency of Effect Across 4 Clinical Trials (S17.004). Neurology. 92(15_supplement). 3 indexed citations

Dodick, David W., Peter J. Goadsby, Stephen D. Silberstein, et al.. (2017). Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003). Neurology. 88(16_supplement). 9 indexed citations

Dodick, David W., Peter J. Goadsby, Stephen D. Silberstein, et al.. (2014). Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. The Lancet Neurology. 13(11). 1100–1107. 299 indexed citations breakdown →

10.

Duncan, Marilyn J., et al.. (2012). Influence of aging on Bmal1 and Per2 expression in extra-SCN oscillators in hamster brain. Brain Research. 1491. 44–53. 54 indexed citations

11.

Almond, Sarah, Megan E. Roberts, Jeff Smith, et al.. (2008). It is not what you do, it is the way that you do it: impact of a care pathway for appendicitis. Journal of Pediatric Surgery. 43(2). 315–319. 24 indexed citations

12.

Smith, Jeff, et al.. (2005). 4-Hydroxynonenal disrupts zinc export in primary rat cortical cells. NeuroToxicology. 27(1). 1–5. 13 indexed citations

13.

Lacey, L.F., et al.. (1994). Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB). European Journal of Clinical Pharmacology. 47(2). 177–80. 12 indexed citations

14.

Nwokolo, CU, Jeff Smith, A. M. Sawyerr, & R E Pounder. (1991). Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.. Gut. 32(12). 1455–1460. 52 indexed citations

15.

Prewett, Emily, Jeff Smith, Chuka Nwokolo, et al.. (1991). Eradication of Helicobacter pylori abolishes 24‐hour hypergastrinaemia: a prospective study in healthy subjects. Alimentary Pharmacology & Therapeutics. 5(3). 283–290. 62 indexed citations

16.

Pounder, R E, S Lanzon-Miller, Jeff Smith, et al.. (1990). Royal Free Hospital Protocol for 24-Hour Intragastric Acidity and Plasma Gastrin Concentration. Digestive Diseases. 8(1). 10–17. 16 indexed citations

17.

Nwokolo, Chuka, Jeff Smith, C. J. Gavey, A. M. Sawyerr, & R E Pounder. (1990). Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Alimentary Pharmacology & Therapeutics. 4(S1). 29–45. 125 indexed citations

18.

Smith, Jeff, C. J. Gavey, CU Nwokolo, & R E Pounder. (1990). Tolerance during 8 days of high‐dose H₂‐blockade: placebo‐controlled studies of 24‐hour acidity and gastrin. Alimentary Pharmacology & Therapeutics. 4(S1). 47–63. 24 indexed citations

19.

Nwokolo, Chuka, C. J. Gavey, Jeff Smith, & R E Pounder. (1989). The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Alimentary Pharmacology & Therapeutics. 3(1). 29–39. 57 indexed citations

20.

Gavey, C. J., Jeff Smith, CU Nwokolo, & R E Pounder. (1989). The effect of SK&F 94482 (BMY‐25368) on 24‐hour intragastric acidity and plasma gastrin concentration in healthy subjects. Alimentary Pharmacology & Therapeutics. 3(6). 557–564. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact